rfhg_209105.1

Basic information about the TSS

---

TSS ID: rfhg_209105.1 Species: human Chr: chr19		Start: 17226199 End: 17226209 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC029361:0 GeneID: 79629 HGNC/MGI_ID: HGNC:26221 UniProt_ID: Nearer transcript ids and distances: ENST00000602236.5:4 ENST00000601576.1:13 ENST00000601529.5:16 ENST00000599588.5:17 ENST00000215061.9:17 NM_024578.3:17 BC038945:30 ENST00000594283.5:34 AK026362:37 CU688632:39 HQ447782:39 ENST00000600232.5:44 ENST00000597836.5:406 view more...

Gene_name: occludin/ELL domain containing 1 Gene_symbol: OCEL1 Gene_synonyms: FLJ22709 Gene_source: HGNC:26221

TATA-Box annotation

---

Distance to TSS:	-22
Nearest PromoterID:	NM_024578
Entrez ID:	79629
Nearest Unigene:	Hs.422676
Nearest Refseq:	NM_024578
Nearest Ensembl:	ENSG00000099330
Gene Name:	occludin/ELL domain containing 1
Gene Alias:	FWP009|S863-9
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.818182
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@OCEL1 p2@OCEL1 p3@OCEL1 p5@OCEL1 p6@OCEL1
Sample		p1@OCEL1	p2@OCEL1	p3@OCEL1	p5@OCEL1	p6@OCEL1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.16	8.38	0.00	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.94	6.68	0.61	0.00	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.92	6.75	0.00	0.00	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.36	8.11	0.42	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.25	6.30	0.45	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.43	4.07	0.00	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	18.96	13.51	0.22	0.00	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.50	12.84	0.73	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.31	16.88	0.85	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	34.78	22.61	1.74	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	40.02	28.30	0.40	0.40	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	37.81	26.43	0.00	0.00	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	10.16	17.09	1.93	1.29	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.37	13.68	0.75	1.65	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	8.12	17.13	1.32	1.10	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.05	16.35	1.26	2.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.95	17.04	1.53	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.81	13.08	1.27	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.06	17.06	1.60	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.63	14.44	1.96	1.50	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	9.62	12.83	1.74	1.34	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.36	12.77	0.52	1.38	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.47	12.15	1.55	1.42	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.41	13.10	1.46	1.21	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.67	14.71	0.77	1.81	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.18	13.93	1.27	0.95	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	19.23	2.75	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.90	11.32	2.12	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.95	12.60	0.97	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	6.33	9.77	1.63	1.99	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.96	12.14	0.84	1.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.21	12.50	0.98	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.13	14.14	2.32	2.11	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.57	11.38	1.32	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.28	10.28	1.31	1.31	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.77	8.81	0.96	0.77	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.56	10.63	0.41	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.65	7.86	1.41	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.02	10.26	0.54	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.92	10.32	0.96	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.23	8.70	0.71	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.61	9.08	0.73	0.59	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.27	10.76	0.21	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.22	11.01	1.40	1.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.42	9.64	1.41	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	8.84	5.58	2.09	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.40	9.12	1.20	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.64	7.15	1.19	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.22	5.74	0.24	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.48	6.87	0.40	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.56	7.17	0.61	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	4.23	7.34	1.56	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3.55	4.26	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	3.31	4.31	0.99	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.03	5.87	1.68	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3.21	4.13	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	3.24	4.86	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	3.85	1.28	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.97	4.09	0.00	1.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	5.64	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1.68	1.68	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	8.76	1.59	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.12	5.10	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.87	5.20	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.97	4.97	1.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.75	6.34	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	6.94	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.38	1.88	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.91	6.29	2.98	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.97	3.71	2.78	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.01	5.81	1.22	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	23.12	3.17	2.22	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	29.04	2.41	2.09	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	21.37	3.18	2.04	0.13	0.51
Adipocyte - omental, donor2	11474-119C7	17.94	1.49	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	14.07	1.67	1.34	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	15.95	3.19	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	24.19	4.40	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	10.84	3.16	1.35	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	29.89	3.65	1.91	0.70	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	10.37	3.52	1.17	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	10.81	3.09	2.32	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	18.40	3.35	2.23	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	18.22	5.29	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	24.93	2.82	2.49	0.32	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	14.52	2.90	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	16.00	2.67	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.03	3.34	4.45	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	27.45	2.91	2.91	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	21.85	3.27	2.51	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	21.27	1.64	1.96	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	22.84	3.04	4.57	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	10.17	8.18	0.66	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	12.19	5.02	2.87	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	5.99	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.95	1.44	0.54	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	1.67	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	21.16	2.67	1.03	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	25.75	4.58	3.66	0.69	0.46
Anulus Pulposus Cell, donor2	11463-119B5	11.02	4.16	1.22	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	3.59	1.35	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	8.68	6.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.37	5.08	1.49	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	7.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	1.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	3.90	0.65	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	5.83	3.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	6.53	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	3.39	1.13	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	9.43	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.93	6.26	1.65	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	8.19	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.98	3.02	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	7.50	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.31	5.48	1.13	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.22	6.68	2.67	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	5.85	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.81	5.47	1.00	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	2.40	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.03	5.15	1.20	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	5.34	1.94	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	5.69	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	13.33	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	3.99	0.00	0.57	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.99	3.42	1.28	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.48	5.68	1.81	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.32	2.82	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.68	8.04	1.29	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	2.85	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	5.26	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.22	5.72	1.51	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.68	5.09	1.02	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.39	7.13	1.27	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	9.53	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.34	3.88	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.66	5.50	1.27	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.54	4.93	1.16	0.87	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	5.67	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.63	5.76	0.85	0.51	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.29	6.22	1.29	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	6.02	3.01	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	3.64	1.46	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.90	5.52	0.69	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.81	4.32	0.25	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.57	4.34	0.41	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.90	7.34	1.53	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	3.35	2.39	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.43	3.33	0.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	7.63	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.42	4.98	1.11	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.21	5.30	1.32	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	7.27	1.09	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	13.51	7.37	1.72	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	12.49	5.31	2.23	0.17	0.51
Astrocyte - cerebellum, donor3	11661-122F5	15.10	7.55	1.47	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	8.02	4.53	1.39	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	7.28	4.37	0.81	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	5.82	3.73	0.45	0.15	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	7.23	4.70	1.72	0.00	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5.39	5.64	1.00	0.00	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.35	3.30	0.91	0.00	0.34
Basophils, donor1	12241-129G9	30.08	0.26	1.05	0.26	0.78
Basophils, donor2	12242-129H1	18.40	0.36	0.72	0.00	0.72
Basophils, donor3	12243-129H2	20.58	0.15	2.50	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	5.61	4.10	1.51	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	18.74	6.40	3.20	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	8.16	1.26	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.24	4.99	0.83	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.07	5.76	0.92	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	8.82	6.84	1.44	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.75	12.57	1.34	0.21	1.34
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.82	23.52	2.10	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	3.52	6.72	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	25.92	0.00	1.13	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	18.93	0.19	0.74	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	18.88	0.22	1.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	29.15	0.57	2.55	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.12	1.14	3.41	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.30	0.66	2.30	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	13.59	0.00	1.16	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	6.03	0.30	0.91	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	12.79	0.24	0.95	0.24	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.54	0.33	0.33	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.14	0.28	0.83	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.45	0.74	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.03	0.00	0.98	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	6.94	0.00	1.42	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	8.05	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.62	0.00	0.94	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.45	1.06	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	1.11	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	8.92	0.15	0.89	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.59	0.80	0.20	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	7.50	0.42	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.47	0.69	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.46	1.58	0.68	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	4.80	0.44	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.07	0.00	0.81	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	7.15	0.52	0.87	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.84	0.00	2.10	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.51	0.00	0.55	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	1.06	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.58	0.88	0.88	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.07	0.35	0.70	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.04	0.00	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.29	0.00	1.08	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	0.82	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.49	0.93	0.70	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.62	0.70	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	32.48	0.87	2.62	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	41.12	0.23	3.46	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	45.27	0.43	1.95	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	86.58	0.93	4.67	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	57.11	0.87	4.19	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	77.37	0.45	4.46	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	52.82	0.00	0.77	0.00	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	41.50	0.44	1.10	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	37.27	0.42	1.68	0.00	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	2.03	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	17.63	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	5.18	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	32.52	6.93	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	26.80	2.68	2.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	23.87	2.11	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	27.45	1.57	0.78	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	26.37	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	11.51	2.47	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	11.61	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	14.64	3.53	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.68	5.25	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	6.79	1.60	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	3.01	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	5.06	1.69	0.00	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	8.27	4.88	2.25	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	9.47	5.41	1.58	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	23.92	1.43	2.14	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	14.08	0.61	1.22	0.00	1.84
CD4+ T Cells, donor3	11382-118B5	15.86	2.13	1.22	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	58.45	1.79	4.08	0.00	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	42.22	3.14	3.82	0.00	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	43.69	4.02	3.74	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	27.97	4.27	0.47	0.00	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	42.14	5.62	2.81	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	0.00	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	32.52	1.73	4.05	0.00	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	16.61	3.22	2.71	0.00	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.57	3.22	2.90	0.00	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	34.07	0.00	2.24	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	29.70	0.70	1.75	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.48	2.20	1.76	0.00	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	55.23	1.26	3.37	0.00	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.10	2.91	2.91	0.00	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	29.74	2.00	2.34	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	33.18	1.63	1.63	0.00	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	23.05	2.14	3.22	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	35.79	1.11	5.75	0.00	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.94	2.82	3.25	0.22	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	28.58	2.94	2.52	0.00	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	27.81	0.51	1.01	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	28.16	1.30	1.73	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.02	2.18	0.87	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.61	2.47	4.45	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	23.08	3.69	3.69	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	2.79	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	40.43	6.92	3.32	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	34.85	4.91	3.44	0.25	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	31.51	3.22	1.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	24.93	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	22.26	1.96	1.31	0.33	1.64
CD8+ T Cells, donor2	11307-117C2	16.14	1.88	0.75	0.38	1.13
CD8+ T Cells, donor3	11383-118B6	25.50	2.78	1.26	0.00	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2.75	7.11	0.69	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.03	7.43	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.56	5.20	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.90	7.21	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	8.40	1.44	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.87	5.46	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.69	6.74	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.00	5.79	0.00	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.16	9.15	0.23	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	3.32	7.85	0.60	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.52	5.23	0.29	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.33	6.66	0.80	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	4.82	8.76	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.74	13.66	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	8.20	0.00	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.96	6.48	0.72	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.03	7.48	0.29	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.66	6.13	0.24	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.17	7.61	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.92	6.77	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.81	8.01	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.35	5.74	0.38	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	9.06	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	4.54	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	5.62	10.44	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	3.50	6.99	0.70	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	5.01	16.03	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	20.11	5.48	3.66	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	2.96	1.48	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	13.89	10.52	1.68	0.84	0.11
Chondrocyte - de diff, donor1	11261-116G1	3.81	3.81	0.69	2.08	0.35
Chondrocyte - de diff, donor2	11338-117F6	9.60	5.33	1.42	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	9.90	5.23	0.34	1.37	0.11
Chondrocyte - re diff, donor2	11339-117F7	16.11	3.58	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.13	11.32	0.81	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	15.26	5.51	1.49	0.00	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	16.67	3.63	1.92	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	12.12	3.81	0.97	0.18	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	39.98	10.09	2.38	0.73	0.18
Corneal Epithelial Cells, donor1	11526-119I5	12.08	5.49	1.32	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	10.24	1.14	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.39	3.58	0.26	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.20	1.98	2.31	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.46	1.89	1.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.63	1.19	1.73	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	6.83	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.14	0.65	1.96	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3.87	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	9.17	4.17	0.83	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	4.11	2.93	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.62	5.37	0.85	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	8.26	1.97	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.44	5.82	1.16	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	7.29	6.12	2.12	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	6.49	4.38	0.88	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.20	4.21	0.44	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	12.17	6.39	1.22	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.43	5.36	0.85	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	3.57	0.89	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	9.37	5.21	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	9.93	3.54	2.27	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	5.60	3.20	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	6.81	1.05	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	7.33	4.85	1.49	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	4.35	3.48	0.65	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	8.79	4.52	0.85	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	7.96	3.41	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	9.78	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	5.81	2.51	0.63	0.16	0.31
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	54.46	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	39.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.35	4.40	0.98	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	6.24	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	6.57	4.52	1.23	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.47	6.02	0.99	0.55	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.10	6.07	0.98	0.43	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.52	4.24	0.73	0.24	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.42	6.28	0.82	0.14	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.86	6.33	1.48	0.32	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	8.96	3.69	2.11	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	7.31	4.65	1.99	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	11.34	6.80	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	5.31	12.13	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	16.88	8.99	0.63	0.47	0.79
Fibroblast - Cardiac, donor4	11452-119A3	13.03	5.15	0.91	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	9.52	3.68	1.14	0.25	0.38
Fibroblast - Cardiac, donor6	11460-119B2	7.73	4.09	0.91	0.30	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.46	4.29	1.88	0.13	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.14	3.45	1.29	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	2.93	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.76	11.76	0.92	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	22.39	6.95	3.56	0.51	0.51
Fibroblast - Dermal, donor1	11269-116G9	3.05	13.38	0.47	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	9.91	5.19	1.89	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.84	6.17	0.97	0.48	0.12
Fibroblast - Dermal, donor4	11450-119A1	4.52	5.20	0.90	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	4.01	4.01	0.87	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	3.74	4.87	0.65	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	12.29	4.37	2.29	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.29	6.81	0.79	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	11.60	6.59	2.64	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	18.76	6.28	2.51	0.39	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	12.47	3.12	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.28	5.46	0.35	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	8.11	6.24	0.78	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	6.90	3.25	1.49	0.54	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.70	9.17	2.47	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	7.46	4.68	2.34	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.50	3.41	1.23	0.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	6.14	5.05	0.44	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.53	5.87	1.32	0.59	0.15
Fibroblast - Lung, donor1	11270-116H1	13.59	8.16	4.08	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	5.97	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.25	6.54	1.48	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	24.16	5.83	3.33	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	6.99	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.51	6.16	1.96	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	20.30	12.59	2.44	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.25	4.27	1.16	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	6.83	5.46	1.52	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	9.79	7.65	1.22	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.78	5.72	1.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.02	2.97	1.62	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.12	4.75	0.93	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.85	4.09	1.55	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.54	7.72	1.63	0.61	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	6.01	2.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.40	7.91	1.98	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	8.14	3.97	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.88	7.46	1.07	0.89	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	4.93	6.70	0.59	0.59	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.92	4.21	2.11	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.07	6.48	1.08	0.97	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.63	4.30	1.27	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	10.67	6.07	1.31	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5.41	3.81	1.80	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	8.54	4.32	2.11	0.60	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	8.76	3.02	0.00	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.85	7.04	0.91	0.91	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.56	7.18	1.20	1.03	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.87	2.30	2.30	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.99	4.69	1.38	0.32	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	10.63	7.08	2.19	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.21	3.14	1.57	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	5.23	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.75	5.03	1.39	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.33	5.47	0.52	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	7.15	3.07	1.02	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.20	15.31	6.12	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	21.06	8.93	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	23.11	11.70	2.85	0.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	18.20	9.38	2.76	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	4.57	7.76	1.37	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	22.19	15.06	2.18	0.20	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	11.10	9.25	1.59	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	4.24	8.15	1.30	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.46	17.25	2.21	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	26.14	8.48	4.24	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	22.17	9.36	1.97	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.88	7.79	1.34	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	19.45	10.65	2.48	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.69	8.44	3.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.03	6.10	3.05	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	25.10	10.50	2.74	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	23.42	8.97	2.74	0.00	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.45	8.74	2.19	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	34.28	9.75	1.77	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	20.03	8.90	1.59	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.70	4.92	2.01	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	22.18	6.86	1.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	18.15	6.11	2.21	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.52	7.71	2.04	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.13	11.76	3.75	0.21	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.55	11.78	4.95	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	20.69	7.97	2.21	0.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.88	6.99	2.33	0.08	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.19	5.92	2.86	0.00	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.25	7.43	3.30	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	23.64	4.73	1.73	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.35	6.17	1.67	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.45	8.82	5.29	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	34.19	7.87	2.58	0.61	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.80	6.65	2.59	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	39.45	6.74	2.57	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.18	7.68	2.94	0.38	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	7.75	3.80	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	30.10	8.21	4.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.82	6.27	2.40	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.27	9.00	2.63	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.85	7.01	3.37	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	13.80	3.43	1.57	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.45	6.95	2.14	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.23	4.90	1.38	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.97	5.05	1.81	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.14	4.88	4.07	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.07	5.71	2.77	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.71	4.39	2.41	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	38.68	11.90	9.92	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.26	5.01	2.64	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.57	4.64	2.62	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	47.27	10.42	4.07	0.25	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	28.07	7.56	3.98	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.82	9.71	3.39	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	33.14	10.64	2.86	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.65	7.20	3.76	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.13	4.24	1.70	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.37	5.53	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	4.95	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.60	4.25	2.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	8.02	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	3.48	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.34	3.91	2.28	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	17.30	4.12	2.88	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.91	4.47	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	15.03	6.54	3.27	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	2.52	5.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.81	5.73	2.23	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.95	3.06	1.36	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	17.18	5.73	2.86	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	17.46	5.62	3.55	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	1.69	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	13.67	4.97	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	8.28	2.30	0.23	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	11.53	6.15	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.76	3.91	1.96	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	17.39	4.68	2.68	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.04	8.86	3.85	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	11.98	5.14	1.03	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	4.97	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.71	7.55	0.94	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.21	7.24	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	18.31	9.66	3.56	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.14	5.98	1.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	27.63	12.83	3.45	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	21.25	14.17	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	22.17	4.67	1.75	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	35.55	7.90	3.95	0.44	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	21.19	3.39	3.39	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.76	2.91	1.46	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	3.42	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.13	6.65	3.33	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	21.36	5.62	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.81	9.83	2.22	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.53	5.43	1.67	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.53	8.70	2.55	0.58	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	16.04	5.57	2.36	0.00	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.47	7.28	1.59	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.68	9.29	1.75	0.33	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.11	8.38	2.58	0.43	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.92	6.03	1.29	0.00	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.33	7.97	1.62	0.75	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.84	7.21	1.72	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	8.97	3.52	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.87	0.56	1.68	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.37	6.49	1.30	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	18.34	6.00	2.12	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	30.51	10.90	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.39	4.20	1.05	0.70	0.17
Hepatocyte, donor1	11523-119I2	60.53	9.68	3.63	1.21	1.21
Hepatocyte, donor2	11603-120I1	58.18	7.54	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	40.49	10.43	0.61	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	16.97	11.10	0.65	0.65	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	50.34	14.51	1.75	0.00	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.03	7.27	1.10	0.00	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	50.94	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	26.70	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	77.53	1.38	2.77	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	47.55	0.00	2.50	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	130.55	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	76.89	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	41.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	103.96	9.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	53.35	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	25.41	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	42.35	78.08	5.29	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	44.35	3.33	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	73.34	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.71	53.54	1.26	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	51.04	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.90	69.13	3.88	1.94	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	57.96	3.22	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	35.84	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.82	63.56	3.26	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.73	49.12	3.78	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	29.74	64.29	3.21	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.01	34.16	0.92	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	75.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	22.66	42.01	0.94	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	17.23	39.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	25.83	53.81	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	35.57	59.71	3.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	30.61	51.01	6.38	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	61.97	3.65	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	56.41	4.28	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	82.96	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	22.53	39.82	2.16	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	80.78	5.27	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	37.72	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	30.60	55.63	4.17	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	61.97	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	81.05	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	61.04	2.62	1.74	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	76.49	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	41.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	26.67	43.74	2.13	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	85.90	4.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	65.54	5.70	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	69.95	5.52	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	60.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	37.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	23.26	44.41	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7.34	6.94	2.20	0.08	0.16
Keratinocyte - epidermal, donor2	11349-117G8	4.69	2.34	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	3.60	4.92	1.61	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	11.35	7.27	0.91	0.23	0.11
Keratocytes, donor1	11527-119I6	5.16	16.50	0.69	1.38	0.00
Keratocytes, donor2	11607-120I5	12.89	7.03	3.52	0.00	0.00
Keratocytes, donor3	11688-122I5	13.83	14.03	1.38	0.79	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	10.79	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	17.42	6.34	2.08	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	11.60	4.84	1.82	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.37	4.51	0.47	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.65	3.35	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.91	2.68	0.94	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.22	2.69	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	3.78	0.63	0.63	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.54	3.02	0.54	0.22	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	3.28	1.23	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.88	4.80	1.01	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.84	2.53	0.84	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.93	1.58	1.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	10.66	2.71	0.00	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.15	2.78	0.56	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	5.23	1.05	1.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.40	5.25	0.95	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	14.42	3.71	1.37	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.47	1.85	0.92	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.53	3.12	1.56	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.67	3.84	1.65	0.18	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.86	2.63	2.96	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.18	4.39	1.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.44	2.24	1.49	0.75	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	0.97	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.35	3.23	0.81	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.54	1.97	0.91	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	3.11	2.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.79	2.93	0.84	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.19	2.56	0.75	0.45	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	2.06	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.97	3.01	1.88	0.38	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	11.98	3.07	1.17	0.21	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.75	3.39	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.59	3.97	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	13.01	3.35	0.62	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.00	4.44	1.85	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.37	0.99	0.49	0.99	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.27	2.06	1.51	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.36	3.22	0.32	0.64	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.22	3.04	1.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.76	2.24	0.98	0.56	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.89	2.49	1.42	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	3.39	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.51	3.27	1.71	0.47	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.52	1.79	1.79	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.19	3.27	1.63	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	15.30	4.47	1.88	0.00	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.40	3.84	1.11	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.48	4.10	0.77	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.25	3.88	0.60	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	6.80	0.00	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	3.84	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	10.39	3.71	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.69	5.08	0.85	0.42	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	3.52	0.70	0.00	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	5.60	0.93	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.21	5.67	1.55	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	8.33	1.19	0.00	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.67	8.37	1.13	0.23	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.02	2.91	0.58	0.29	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.55	4.50	1.35	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.77	6.91	1.35	0.27	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.38	6.16	1.54	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.47	2.82	0.35	0.00	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	6.66	1.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.73	3.06	1.53	0.00	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.01	6.14	1.33	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.71	3.97	1.13	0.19	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.82	4.29	0.00	0.61	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.94	6.52	1.63	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	9.58	5.00	0.21	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.81	1.68	0.56	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	3.09	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.03	1.74	0.00	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.16	2.99	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	3.32	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.20	4.60	0.71	0.71	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.48	2.95	0.37	0.00	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	5.76	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.90	6.91	0.77	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.76	4.53	0.00	0.57	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	4.10	0.82	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.94	5.42	1.36	0.00	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	11.49	5.03	1.44	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.23	4.48	0.00	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.89	2.23	0.74	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.91	4.74	0.43	0.00	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	14.56	2.57	0.86	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.00	5.00	1.00	0.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.07	5.43	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	5.69	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.00	4.12	0.69	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.59	4.29	0.54	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	4.04	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.22	4.82	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	16.28	6.98	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	4.23	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.80	4.00	0.40	1.60	4.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	7.27	1.45	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	9.96	3.07	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.87	5.43	1.48	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	2.82	2.82	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	16.59	6.54	1.01	0.50	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.52	4.96	0.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	8.61	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	8.02	0.89	0.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	12.12	10.17	1.56	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	5.94	0.00	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	13.49	6.23	0.52	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	13.13	5.69	1.75	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	11.74	5.03	0.00	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.95	3.97	0.00	0.00	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.80	8.49	0.00	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	3.54	3.54	0.00	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.02	4.81	0.96	0.96	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	4.77	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.68	4.25	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	14.53	8.99	0.69	0.00	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	3.04	0.38	0.38	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.43	3.61	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.72	5.44	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.77	6.34	1.90	0.32	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	4.80	5.86	0.00	0.53	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	11.49	6.32	0.00	0.57	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	6.17	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	12.73	3.54	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	17.59	7.38	0.00	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	3.33	1.25	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	4.70	0.00	0.00	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.27	2.92	0.42	0.42	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.08	4.65	0.46	0.00	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	6.69	0.00	0.00	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	7.48	3.74	1.60	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.55	4.04	0.81	0.00	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	6.22	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	15.39	6.27	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.90	4.60	0.77	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.11	3.28	0.55	0.00	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	10.25	4.90	0.45	0.00	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.00	4.42	0.26	0.00	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.28	1.99	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	6.24	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	18.92	0.46	2.51	0.46	0.46
Macrophage - monocyte derived, donor2	11313-117C8	7.71	0.55	1.47	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	14.03	1.18	1.97	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.15	5.31	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	9.67	3.33	1.43	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	10.42	5.00	0.97	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	1.79	3.69	0.50	0.20	0.10
Mammary Epithelial Cell, donor2	11350-117G9	4.34	2.32	0.87	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	5.99	7.98	0.75	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	11.52	4.75	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	36.66	3.03	3.35	0.32	0.76
Mast cell, donor2	11565-120D8	16.94	0.89	1.78	0.00	0.30
Mast cell, donor3	11566-120D9	23.41	2.93	2.70	0.23	0.23
Mast cell, donor4	11567-120E1	25.35	5.14	3.19	0.35	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	42.69	4.66	4.10	0.11	1.66
Mast cell, expanded and stimulated, donor8	11942-126A7	33.85	3.50	2.33	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	53.00	2.52	2.75	0.23	1.26
Mast cell, expanded, donor8	11941-126A6	63.10	4.02	4.35	0.33	2.68
Melanocyte - dark, donor1	11502-119F8	28.46	4.18	1.69	0.50	0.90
Melanocyte - dark, donor2	11582-120F7	27.34	4.50	1.04	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	35.86	8.11	3.55	0.36	0.58
Melanocyte - light, donor1	11274-116H5	37.61	11.28	3.53	0.24	0.24
Melanocyte - light, donor2	11351-117H1	50.50	10.24	4.78	0.00	0.68
Melanocyte - light, donor3	11423-118G1	19.08	5.20	3.47	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	36.03	6.56	2.50	0.10	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	26.36	10.22	2.42	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	51.43	5.09	3.48	0.27	0.80
Meningeal Cells, donor1	11493-119E8	11.41	5.33	1.98	0.00	0.37
Meningeal Cells, donor2	11573-120E7	16.73	4.40	1.76	0.00	1.32
Meningeal Cells, donor3	11654-122E7	9.05	4.32	1.22	0.08	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	13.69	5.99	2.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.65	4.43	0.60	0.50	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	68.34	30.23	9.20	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	5.23	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	5.02	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.89	3.81	1.27	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.54	3.52	1.51	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.06	5.93	1.54	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	8.77	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.41	5.12	2.46	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.74	9.83	1.66	1.94	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	35.69	5.58	3.72	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.55	10.66	1.58	0.66	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.78	6.23	0.30	0.00	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	11.68	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.69	14.09	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.38	4.25	2.48	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	20.95	7.82	0.94	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	8.71	1.45	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	10.61	3.71	1.86	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	12.51	6.51	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	8.74	2.75	1.30	0.14	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	0.00	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	16.99	0.99	1.97	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.83	0.29	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.88	0.62	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.75	0.21	1.24	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	0.00	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	19.77	0.25	3.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.84	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	22.35	1.42	1.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.32	0.40	2.38	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	22.12	0.88	1.77	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.12	0.38	1.90	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	1.32	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.34	0.42	1.49	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	15.80	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.80	0.25	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.18	0.00	1.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	0.00	1.11	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.66	0.00	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.05	1.05	1.47	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.38	0.61	0.41	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.52	0.43	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.67	0.22	1.11	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.29	0.66	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.42	0.27	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.94	0.29	1.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.20	0.00	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.13	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.71	0.99	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.15	2.39	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2.19	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.39	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.54	1.12	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	0.00	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	0.58	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.75	0.30	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.76	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.97	0.00	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.19	1.11	0.41	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.03	1.04	0.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.88	0.53	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.78	0.30	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.28	0.42	1.27	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	23.57	0.96	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.50	0.22	1.55	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.38	1.52	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.19	0.57	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.06	0.49	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.82	0.65	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.29	0.59	2.06	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.61	0.00	3.46	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.01	0.82	0.41	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	23.23	0.00	2.08	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	37.46	0.66	1.97	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	1.05	3.16	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.07	0.20	1.58	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.40	1.50	2.25	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.65	0.27	0.80	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.66	1.36	1.47	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	28.21	1.10	1.10	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	22.98	2.14	2.14	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	28.28	2.02	3.03	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.12	1.26	1.26	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	1.36	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	20.25	0.81	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	17.13	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	6.03	3.02	0.86	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	4.18	2.09	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	1.33	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.59	3.34	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	6.27	3.23	0.76	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	1.36	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	3.68	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.28	2.09	1.67	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.18	2.56	1.39	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.11	5.40	2.16	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.93	3.15	2.10	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	2.98	1.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.50	2.44	1.89	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.61	3.40	2.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.53	2.29	1.31	0.65	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.48	4.01	1.46	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.96	4.24	1.06	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	0.60	1.20	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.46	2.63	2.95	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.85	1.30	0.49	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.11	4.94	1.06	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	1.41	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.14	1.38	0.92	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5.78	1.61	1.29	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	10.00	4.83	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	10.11	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.69	3.12	1.11	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.66	0.85	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.88	1.19	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.30	3.43	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.00	3.67	0.67	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	7.21	0.90	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.56	1.98	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	2.79	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	8.32	1.51	0.38	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	1.96	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	2.61	1.31	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.69	4.52	1.81	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	1.33	2.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	2.48	2.48	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.59	2.30	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	7.56	3.63	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.28	4.86	0.44	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	2.03	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.27	3.05	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	2.83	1.89	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.66	1.51	0.91	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	1.58	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	5.67	2.27	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	5.34	4.22	0.87	0.25	0.12
Myoblast, donor2	11322-117D8	13.04	4.41	1.15	0.58	0.38
Myoblast, donor3	11398-118D3	9.25	5.21	2.02	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	14.16	4.96	0.58	0.15	0.58
Natural Killer Cells, donor1	11230-116C6	31.67	2.15	0.92	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	17.19	2.11	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	28.34	1.10	1.84	0.00	0.37
Neural stem cells, donor1	11275-116H6	5.81	2.90	1.09	0.00	0.73
Neural stem cells, donor2	11352-117H2	5.78	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	5.69	4.55	0.00	0.00	0.00
Neurons, donor2	11574-120E8	8.81	4.84	0.66	0.00	0.00
Neurons, donor3	11655-122E8	2.47	3.29	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	63.10	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	26.09	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	20.16	1.22	1.22	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	19.95	10.45	3.21	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	26.05	8.47	1.95	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	9.83	5.01	1.60	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	9.77	5.23	2.62	0.83	0.14
Olfactory epithelial cells, donor2	11934-125I8	6.95	3.18	0.43	0.29	0.43
Olfactory epithelial cells, donor3	11935-125I9	6.36	3.75	1.93	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	10.42	7.99	1.07	1.07	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	20.46	7.22	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	8.93	3.19	1.28	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	11.43	2.29	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	3.72	1.24	2.48	0.00
Osteoblast, donor1	11277-116H8	13.29	5.86	2.15	0.20	0.00
Osteoblast, donor2	11354-117H4	3.51	3.51	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	7.29	4.09	1.07	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	10.36	5.39	1.35	0.34	0.00
Pericytes, donor1	11491-119E6	33.49	6.45	4.23	0.45	0.45
Pericytes, donor2	11571-120E5	23.09	6.11	2.49	0.00	0.45
Pericytes, donor3	11652-122E5	19.33	7.73	2.03	0.81	0.00
Perineurial Cells, donor1	11499-119F5	10.06	8.59	0.68	0.23	0.23
Perineurial Cells, donor2	11579-120F4	21.44	4.51	2.39	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	39.20	0.64	1.59	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	31.83	0.49	3.18	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	26.14	0.52	3.36	0.00	0.65
Placental Epithelial Cells, donor1	11278-116H9	9.57	3.11	0.48	0.00	0.72
Placental Epithelial Cells, donor2	11355-117H5	21.07	3.33	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.55	4.71	0.79	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	15.51	4.11	1.27	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	15.38	3.56	0.94	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.01	1.44	1.70	0.00	0.52
Preadipocyte - breast, donor2	11328-117E5	16.44	2.93	0.90	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	13.21	4.48	0.96	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	18.77	4.36	1.31	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	13.90	2.15	1.58	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	11.81	6.89	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.45	4.91	0.92	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	5.49	5.31	1.06	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	6.13	3.75	0.85	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	4.56	5.50	1.40	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	6.44	3.68	2.30	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	3.66	2.51	0.84	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.42	14.03	0.15	0.00	1.36
Prostate Epithelial Cells, donor2	11331-117E8	10.83	7.45	0.81	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	4.96	5.33	0.24	0.18	0.12
Prostate Stromal Cells, donor1	11254-116F3	4.10	3.87	0.91	0.34	0.11
Prostate Stromal Cells, donor2	11332-117E9	5.38	6.45	1.26	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	9.38	4.07	2.19	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.61	5.11	3.28	0.36	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.83	5.34	1.25	0.07	0.35
Renal Epithelial Cells, donor1	11517-119H5	26.38	8.62	3.04	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	10.67	5.69	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	18.00	3.49	1.16	0.11	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	4.09	4.77	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.55	4.31	2.02	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	8.44	4.22	0.67	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	32.61	10.65	1.33	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	14.97	4.62	3.08	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	24.45	6.27	5.02	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	23.58	3.33	3.33	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	9.39	3.49	1.61	0.00	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	1.27	2.11	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.73	3.47	0.96	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	9.59	5.44	1.30	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.79	10.52	2.56	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	6.17	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.28	6.27	1.00	0.00	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	66.82	8.55	1.34	0.53	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	4.47	4.47	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.56	2.75	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.72	10.44	1.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	5.98	5.72	0.91	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	5.26	4.07	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.92	6.13	0.56	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	5.09	4.09	0.50	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5.48	5.83	1.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	7.17	3.70	0.92	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	6.02	4.93	1.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	6.66	4.08	1.06	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	6.09	6.09	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	6.17	5.16	2.15	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	6.87	3.86	1.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	6.86	5.97	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	6.31	5.35	1.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.17	4.38	0.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	6.76	6.58	1.13	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	5.18	5.97	0.66	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.81	7.11	0.88	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	6.11	5.16	1.91	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.19	4.70	1.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.41	5.33	2.24	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.18	4.79	0.85	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.92	5.11	0.91	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	5.64	4.54	1.47	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	8.19	4.97	0.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	5.90	5.43	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.16	4.96	0.79	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	7.72	5.38	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	4.98	3.32	0.83	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	7.08	3.54	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	6.68	4.60	0.42	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	4.17	4.98	1.08	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.28	5.11	1.02	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	6.94	4.24	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.88	5.50	1.03	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	3.84	3.43	0.55	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	5.91	4.76	0.66	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5.11	4.77	1.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	8.58	3.55	1.63	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	5.86	4.80	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	5.95	8.85	1.52	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	8.10	5.95	1.19	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	12.90	9.27	1.81	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	10.26	5.84	1.41	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	8.73	7.69	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.76	6.35	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	8.93	5.39	1.10	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	10.48	10.19	0.58	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	5.48	7.91	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	7.23	7.53	1.21	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	10.86	12.44	0.90	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	13.18	7.79	1.80	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	8.86	9.09	1.18	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	10.46	6.40	1.49	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	6.61	7.81	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	14.11	6.96	1.32	0.38	0.75
Schwann Cells, donor2	11578-120F3	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	12.71	5.70	1.53	0.44	0.00
Sebocyte, donor1	11220-116B5	10.41	15.34	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	5.97	9.19	1.38	0.00	0.00
Sebocyte, donor3	11378-118B1	17.73	11.34	2.47	0.62	0.41
Sertoli Cells, donor1	11255-116F4	14.91	6.63	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	11.30	14.12	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	10.65	8.27	0.97	0.62	0.09
Skeletal Muscle Cells, donor2	11358-117H8	13.01	4.34	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	8.36	9.20	3.34	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	6.44	4.56	0.63	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	5.35	3.57	0.74	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	5.23	3.69	0.15	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	24.32	11.59	2.14	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.98	5.99	2.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6.45	4.46	1.19	0.00	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.63	4.13	1.26	0.08	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.17	8.69	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.49	4.27	0.83	0.14	0.14
Skin - palm, donor1	10286-104F7	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.20	5.91	0.00	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	6.54	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.93	6.75	0.39	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	4.87	3.75	0.70	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	6.19	8.30	0.56	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	7.82	9.30	0.42	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	7.64	8.09	0.60	0.22	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.34	15.43	1.23	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	5.56	8.45	1.33	0.89	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.82	15.87	1.76	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.08	7.96	0.88	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10.24	6.30	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	4.64	11.59	1.55	4.64	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	6.00	3.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.25	7.32	0.80	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.74	5.98	1.55	1.77	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.74	3.46	0.51	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.70	1.95	1.63	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.06	4.43	2.36	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.95	2.42	2.70	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.01	8.78	3.09	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.48	4.26	2.13	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.57	10.10	2.27	1.26	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	11.44	2.86	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.62	2.36	1.33	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.78	3.44	1.51	0.86	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	9.55	4.72	1.47	0.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.14	11.29	0.77	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	3.23	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	2.99	3.29	0.60	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	13.66	10.58	2.39	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.64	11.86	2.43	0.71	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	4.13	5.64	1.21	0.50	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.28	7.74	0.91	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	8.45	9.66	1.81	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	4.50	4.77	0.53	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	8.79	5.46	1.07	0.67	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	8.64	4.63	0.63	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.16	3.80	1.52	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	5.28	7.39	1.21	0.90	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	7.50	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	6.46	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.07	13.49	2.33	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	9.09	1.51	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.01	6.27	1.57	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.21	10.62	1.77	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	7.08	7.58	1.25	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.56	6.07	3.27	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.20	8.78	1.01	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	3.82	8.41	1.78	1.78	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.15	6.39	1.32	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.14	4.75	1.12	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.92	5.11	0.84	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.52	14.76	0.95	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.03	10.03	2.20	0.73	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.08	3.54	1.10	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.19	4.39	0.59	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.35	4.66	1.36	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.93	5.29	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	6.32	1.49	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.62	5.39	0.72	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	6.25	4.26	1.14	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.12	5.51	1.18	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	9.40	6.60	1.27	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	12.78	9.58	2.40	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	2.51	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	4.13	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	8.08	3.53	0.17	0.84	0.34
Synoviocyte, donor2	11368-117I9	7.21	5.36	1.17	0.50	0.17
Synoviocyte, donor3	11440-118H9	11.39	4.69	0.67	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	13.22	11.08	1.79	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	13.87	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	15.75	7.64	3.47	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	5.16	2.87	0.93	0.07	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	6.96	7.73	2.71	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	5.15	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	66.93	10.21	1.85	0.37	0.98
Urethra, donor2	10319-105A4	21.58	3.60	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	10.10	5.31	1.86	0.27	0.00
Urothelial Cells, donor2	11600-120H7	7.21	6.41	1.60	0.00	0.00
Urothelial Cells, donor3	11681-122H7	12.61	6.42	2.29	0.23	0.00
Urothelial cells, donor0	11216-116B1	13.37	7.36	1.56	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	32.92	1.78	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	31.45	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.96	1.37	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	18.59	1.72	1.72	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	38.35	0.58	2.32	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	30.20	0.00	6.25	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	39.47	3.67	2.75	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	0.91	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	9.38	8.51	0.74	0.37	0.62
Wilms' tumor cell line:HFWT	10597-108E3	7.92	4.40	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	11.45	4.75	1.40	0.00	0.00
achilles tendon, donor2	10292-104G4	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	4.59	1.78	1.02	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4.18	17.88	1.63	0.23	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	3.32	2.02	0.24	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.07	7.35	1.90	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.34	7.03	1.97	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	26.65	5.08	2.54	0.21	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.34	4.36	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	10.13	8.81	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	24.09	7.76	2.86	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	4.66	2.33	0.78	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.55	0.18	0.00	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	11.62	6.27	1.16	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	20.19	14.76	2.59	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.61	10.52	1.75	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	16.27	3.25	1.39	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	22.62	9.05	2.06	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	8.90	1.23	0.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	10.67	2.13	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.34	5.76	3.64	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	12.76	2.89	1.68	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	4.90	4.90	0.89	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.34	7.00	2.33	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	16.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	36.91	7.16	5.65	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	13.52	13.08	1.31	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	5.62	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	17.66	12.01	3.06	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	17.68	4.96	1.24	0.78	0.31
adipose, donor1	10184-103D4	5.86	3.52	2.35	0.00	0.00
adipose, donor2	10185-103D5	6.08	6.49	1.62	0.00	0.00
adipose, donor3	10186-103D6	6.81	4.63	0.82	0.00	0.54
adipose, donor4	10187-103D7	14.73	9.53	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.84	13.57	2.53	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.15	15.07	2.80	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	2.14	4.29	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	15.30	3.01	0.46	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	19.27	5.07	0.68	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	11.19	3.24	1.18	0.29	0.00
amygdala - adult, donor10196	10167-103B5	24.90	7.11	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	22.51	8.52	2.43	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	10.97	6.13	2.90	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	14.01	17.95	1.40	1.27	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.37	7.72	0.88	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	21.71	21.38	1.67	0.00	0.33
aorta, adult, pool1	10052-101G7	16.28	5.10	0.39	0.59	0.00
appendix, adult	10189-103D9	22.90	5.05	2.33	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.97	4.82	0.69	0.34	0.00
artery, adult	10190-103E1	16.30	1.36	2.72	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	12.46	3.91	0.43	0.00	0.14
b cell line:RPMI1788	10427-106D4	6.84	5.80	1.34	0.00	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.66	7.21	0.28	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.30	5.95	0.69	0.10	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	4.18	3.51	0.50	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	39.71	4.47	2.24	1.12	1.12
bladder, adult, pool1	10011-101C2	14.23	5.76	0.76	1.96	0.43
blood, adult, pool1	10053-101G8	17.72	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	24.97	0.67	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	24.60	8.20	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	20.27	9.47	3.34	0.56	0.22
brain, fetal, pool1	10085-102B4	5.34	10.69	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	11.89	2.97	0.99	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	41.07	10.98	2.50	0.50	0.75
breast, adult, donor1	10080-102A8	20.83	3.16	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1.27	4.70	0.76	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	9.59	7.73	1.24	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	9.44	4.37	1.61	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.98	14.28	1.21	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	7.99	11.28	2.35	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	44.63	16.84	2.08	0.77	3.39
carcinoid cell line:SK-PN-DW	10719-109I8	8.56	7.29	2.54	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	8.52	10.91	1.60	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	13.82	10.36	4.61	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	15.56	7.53	2.01	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	7.64	3.06	0.76	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	4.39	7.69	0.37	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	11.65	17.48	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	28.61	8.75	1.92	0.43	0.00
cerebellum, adult, pool1	10083-102B2	15.18	10.69	0.69	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	11.62	7.47	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	14.88	4.03	2.02	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	3.65	2.92	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	21.85	51.33	1.73	4.60	2.88
cervical cancer cell line:ME-180	10553-107I4	7.95	1.33	0.33	0.00	0.66
cervix, adult, pool1	10013-101C4	22.15	11.23	1.57	0.63	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.02	11.01	1.39	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	2.61	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	52.44	16.53	5.10	0.62	0.75
choriocarcinoma cell line:SCH	10785-110H2	23.29	7.89	0.99	0.37	2.09
choriocarcinoma cell line:T3M-3	10618-108G6	13.99	5.22	0.47	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	21.65	4.27	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	18.89	3.48	1.79	0.00	0.20
chorionic membrane cells, donor3	12240-129G8	17.03	2.20	2.20	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	2.02	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	6.92	4.80	0.38	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.67	5.70	0.84	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	14.64	30.56	2.57	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	12.58	32.17	1.69	1.21	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.59	31.36	1.22	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	7.66	13.25	0.00	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	21.89	9.38	2.61	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.69	5.71	0.91	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	11.10	6.42	1.39	0.35	0.35
colon carcinoma cell line:CACO-2	10513-107D9	12.45	7.32	0.55	0.37	0.37
colon carcinoma cell line:COLO-320	10420-106C6	5.70	22.04	1.14	1.90	0.00
colon, adult, donor1	10082-102B1	40.46	4.76	1.19	2.38	1.19
colon, adult, pool1	10014-101C5	55.58	5.88	2.94	0.12	1.06
colon, fetal, donor1	10070-101I7	27.19	4.33	2.47	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	4.58	22.92	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	4.25	7.65	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.58	6.94	0.45	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	6.63	8.46	0.42	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	17.47	9.07	1.55	0.55	0.33
cruciate ligament, donor2	10295-104G7	13.78	3.24	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	20.06	4.82	1.61	0.80	0.80
diencephalon, adult	10193-103E4	17.28	6.24	1.20	0.96	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.35	11.71	0.92	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	8.21	4.36	0.26	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2.89	8.67	0.24	0.00	0.24
ductus deferens, adult	10196-103E7	23.42	20.93	2.49	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	2.88	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	48.55	2.21	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	15.28	2.40	0.99	0.33	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	27.09	20.21	0.22	0.22	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.33	5.59	0.72	0.00	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	11.10	11.72	0.62	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	17.25	9.69	1.21	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	11.42	10.81	0.31	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	11.82	13.13	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.74	8.72	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	6.71	11.42	1.27	0.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	37.15	4.50	1.29	0.16	0.96
epidermoid carcinoma cell line:A431	10426-106D3	7.45	8.11	0.67	0.11	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	6.71	5.28	0.66	0.11	0.00
epididymis, adult	10197-103E8	32.65	17.79	2.09	0.21	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	9.40	8.52	1.24	0.00	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2.36	6.69	0.39	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	14.15	11.40	1.97	0.13	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.88	11.61	1.67	0.30	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	13.44	13.11	1.57	0.34	1.23
esophagus, adult, pool1	10015-101C6	18.79	4.57	1.70	0.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	7.89	3.51	0.25	0.13	0.63
eye - muscle inferior rectus, donor1	10272-104E2	4.83	0.00	0.00	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	8.42	6.31	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	10.42	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	9.17	1.15	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	2.91	1.46	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	17.54	8.14	1.27	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	5.26	6.92	0.51	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	6.17	12.11	0.47	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	22.61	8.16	2.25	0.47	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	36.03	3.60	2.70	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.84	9.88	1.65	0.09	0.00
gall bladder, adult	10198-103E9	26.32	5.31	1.93	1.21	0.24
gamma delta positive T cells, donor1	11937-126A2	18.79	0.54	2.15	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	37.72	1.12	3.73	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.76	4.44	1.69	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	25.72	5.42	0.58	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	19.67	13.28	2.46	0.33	0.33
gastric cancer cell line:GSS	10560-108A2	11.90	10.98	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	14.16	11.88	0.91	1.14	0.46
giant cell carcinoma cell line:LU65	10487-107B1	3.33	13.54	0.00	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	7.70	7.14	0.56	0.28	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.23	1.00	0.50	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.67	10.34	1.90	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.39	9.97	1.26	0.56	0.28
glioblastoma cell line:T98G	10485-107A8	6.51	7.28	1.10	0.55	0.11
glioma cell line:GI-1	10413-106B8	11.42	12.30	1.17	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	7.29	10.20	0.00	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	30.02	6.59	2.20	1.46	0.24
globus pallidus, adult, donor10258	10367-105F7	17.80	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	14.92	5.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.52	6.40	0.96	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	18.36	17.91	1.38	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	22.86	13.72	3.20	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	19.97	16.75	4.51	0.00	0.64
hIPS, biol_rep1	14380-156B6	20.12	5.75	0.00	0.00	2.87
hIPS, biol_rep2	14381-156B7	15.09	13.03	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	26.48	11.03	4.41	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	12.93	7.76	1.44	0.00	0.29
heart - mitral valve, adult	10205-103F7	16.44	3.59	1.79	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	21.70	4.97	2.61	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	8.33	3.33	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.00	5.92	2.65	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	25.12	5.54	0.85	0.85	0.00
heart, adult, pool1	10016-101C7	15.18	5.75	0.69	0.92	0.00
heart, fetal, pool1	10046-101G1	17.46	6.88	1.33	0.31	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	11.72	6.48	0.62	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	17.84	3.57	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	25.19	24.31	1.33	0.22	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.48	19.42	0.49	0.49	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.92	23.14	0.91	0.40	0.91
hepatoma cell line:Li-7	10484-107A7	30.36	5.56	0.44	0.00	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3.82	7.94	0.40	0.00	0.80
hippocampus - adult, donor10196	10169-103B7	13.25	6.62	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	21.02	8.57	2.65	1.43	0.41
hippocampus, adult, donor10258	10374-105G5	21.41	2.49	3.49	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	6.70	4.23	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	37.23	12.21	2.44	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.60	10.01	1.57	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	26.15	11.17	2.29	0.25	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	12.41	11.84	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	12.14	8.00	1.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	17.84	8.73	4.93	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	4.96	12.26	0.58	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	3.45	10.56	0.43	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	3.75	12.10	0.83	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	5.92	3.55	0.71	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	6.59	6.43	0.00	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	3.37	2.69	1.35	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	19.40	13.14	1.41	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.26	12.28	2.46	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	13.09	2.62	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	10.50	5.92	2.67	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.72	5.67	2.18	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.49	2.50	2.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.78	4.52	1.70	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.28	6.82	2.27	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.14	4.70	0.63	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.35	1.47	0.82	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.71	3.77	0.58	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	13.75	2.09	1.20	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.53	14.59	4.25	0.18	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	22.25	10.84	3.42	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	28.17	11.02	2.04	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	11.97	7.39	1.06	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.35	6.97	2.53	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.53	9.08	6.36	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.79	7.76	1.03	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.30	7.97	2.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	6.93	8.47	0.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	5.62	4.09	1.28	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	4.54	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.43	5.38	0.67	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.88	14.97	3.86	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	39.22	18.27	4.01	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.34	14.63	6.83	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.81	7.64	3.36	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	3.25	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	16.55	10.92	3.31	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.66	7.11	1.64	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	7.60	9.41	1.81	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.12	8.54	1.42	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	5.97	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	8.40	8.13	1.35	0.27	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	5.39	7.54	1.08	0.00	0.27
immature langerhans cells, donor1	11904-125F5	2.18	0.24	0.00	0.24	0.00
immature langerhans cells, donor2	11905-125F6	3.17	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	25.46	7.95	3.50	0.38	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	9.43	4.88	1.30	0.00	0.33
kidney, adult, pool1	10017-101C8	60.28	9.71	3.10	0.10	0.00
kidney, fetal, pool1	10045-101F9	31.48	6.01	2.26	0.50	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.66	11.93	0.43	0.71	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.47	7.60	0.69	0.55	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.07	9.91	0.18	0.55	0.18
left atrium, adult, donor1	10079-102A7	10.35	5.99	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	13.15	3.03	0.00	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	4.65	5.75	0.82	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	6.11	3.59	1.08	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	2.72	7.61	1.63	0.54	0.00
leiomyoma cell line:15425	10571-108B4	4.13	4.86	0.49	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	19.83	11.45	0.83	0.12	0.24
liposarcoma cell line:KMLS-1	10782-110G8	10.15	3.91	0.78	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	15.72	5.36	1.34	0.12	0.00
liver, adult, pool1	10018-101C9	87.03	21.07	4.05	0.65	0.49
liver, fetal, pool1	10086-102B5	32.92	7.53	0.94	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	16.92	7.15	3.50	0.58	0.29
locus coeruleus, adult, donor10252	10165-103B3	20.49	6.64	1.66	0.74	0.55
locus coeruleus, adult, donor10258	10375-105G6	16.65	7.05	0.85	1.13	0.28
locus coeruleus, newborn, donor10223	10362-105F2	15.98	5.05	1.26	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	6.09	2.63	1.38	0.14	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	15.86	1.38	2.76	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	8.17	3.56	2.11	0.00	0.13
lung, adult, pool1	10019-101D1	28.23	5.67	1.18	1.06	0.47
lung, fetal, donor1	10068-101I5	21.41	7.99	1.14	2.28	0.00
lung, right lower lobe, adult, donor1	10075-102A3	32.53	2.29	3.67	0.46	0.00
lymph node, adult, donor1	10077-102A5	14.20	3.31	0.47	0.00	1.42
lymphangiectasia cell line:DS-1	10727-110A7	10.52	4.60	2.19	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.92	8.00	1.21	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	32.28	2.55	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	58.61	7.10	1.78	0.00	0.00
mature adipocyte, donor2	12232-129F9	72.43	7.47	3.74	1.25	0.62
mature adipocyte, donor3	12233-129G1	72.07	4.27	1.66	1.19	0.24
mature adipocyte, donor4	12234-129G2	57.91	7.11	2.11	1.05	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.34	7.15	0.71	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	5.64	5.64	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	29.61	6.80	5.33	0.37	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	24.14	9.85	4.45	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	12.37	5.12	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	24.98	6.92	4.56	0.51	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	34.59	7.43	3.61	0.42	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	0.00	5.78	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.10	8.26	4.31	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	9.73	11.03	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	25.85	7.74	2.48	0.77	0.00
medulla oblongata, adult, pool1	10038-101F2	18.94	8.41	1.80	0.65	0.65
medulla oblongata, newborn, donor10223	10361-105F1	17.36	12.85	1.04	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	9.30	16.83	1.99	0.44	0.44
medulloblastoma cell line:ONS-76	10759-110E3	4.77	10.88	0.73	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	8.91	5.17	1.29	0.00	0.29
melanoma cell line:G-361	10465-106H6	5.43	12.49	0.54	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	4.52	6.87	0.36	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	1.76	3.52	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	5.96	4.67	2.59	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	7.98	5.68	1.23	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.82	2.73	0.91	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	5.38	2.48	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	3.79	2.67	2.25	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	7.32	3.85	1.16	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	7.63	2.08	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.35	7.55	1.20	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.01	3.57	1.04	0.46	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	7.03	2.12	1.59	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	7.56	3.38	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.11	2.85	1.85	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	16.47	4.61	1.32	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.24	5.53	1.11	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	9.08	6.28	1.75	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.92	3.88	1.22	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.50	5.39	0.36	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.38	5.48	1.55	0.41	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.94	5.47	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.03	1.26	1.26	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.02	1.64	2.09	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.34	3.33	1.93	0.09	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.94	8.10	1.84	1.47	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.59	4.29	0.00	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	9.26	5.89	0.84	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.44	3.65	0.91	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.65	2.56	1.53	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.97	4.45	1.31	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	16.64	2.46	1.23	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.89	4.94	0.71	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.85	5.75	2.37	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.54	5.89	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.51	5.56	1.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	4.04	0.58	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.06	4.69	1.34	0.67	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.62	5.29	1.68	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	12.47	5.87	2.20	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.10	4.03	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.92	4.09	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.18	5.58	2.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	8.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.62	1.30	1.30	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	7.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	5.33	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	4.09	3.27	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.66	4.66	1.17	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	3.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	8.89	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	5.70	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.00	6.90	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	10.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	11.98	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	10.33	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.08	7.33	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	8.74	0.79	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	5.90	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.40	7.48	1.25	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	8.02	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	9.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	5.14	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.77	4.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	36.12	4.95	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	20.19	6.73	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.80	4.45	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	46.75	4.84	2.82	0.40	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	56.70	6.54	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	2.53	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.88	3.64	1.82	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	2.47	3.29	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.10	2.18	1.19	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.90	2.60	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	20.37	4.07	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.15	2.32	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	9.92	9.45	0.24	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	11.12	4.17	0.70	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	9.35	5.34	0.92	0.41	0.41
mesothelioma cell line:Mero-25	10850-111F4	11.80	22.92	0.45	0.45	0.68
mesothelioma cell line:Mero-41	10851-111F5	4.89	5.87	0.24	1.22	0.00
mesothelioma cell line:Mero-48a	10852-111F6	5.98	6.20	0.89	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	2.10	7.36	0.79	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	20.60	11.23	1.53	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	14.16	5.56	1.26	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	7.66	10.15	1.04	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	3.64	3.64	0.99	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	5.25	3.98	0.18	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	10.93	10.76	0.68	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	5.34	2.54	1.02	0.00	0.51
mesothelioma cell line:No36	10857-111G2	19.25	15.66	2.94	0.00	1.63
mesothelioma cell line:ONE58	10858-111G3	7.32	3.52	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	5.57	2.11	1.34	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	7.33	2.56	1.22	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	5.03	4.13	2.15	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.73	12.41	0.65	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.48	5.30	0.00	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	2.76	1.38	0.46	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.80	1.33	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	8.50	20.51	2.03	0.37	0.37
myeloma cell line:PCM6	10474-106I6	19.17	10.67	1.38	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.13	3.04	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	11.38	7.06	2.16	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.01	4.68	0.78	0.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.85	4.78	0.44	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	5.52	4.97	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	4.83	2.53	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	9.92	7.48	1.68	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	7.59	8.01	0.63	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	6.52	8.39	0.19	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7.83	4.51	0.95	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	5.23	2.22	0.48	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	4.63	7.65	0.40	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.18	2.54	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	6.39	3.46	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	4.74	11.16	0.51	0.17	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	0.00	2.40	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	7.05	5.77	0.32	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.08	3.15	2.36	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	16.22	7.22	2.91	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	28.85	12.36	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	30.86	7.25	2.68	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	24.02	4.73	2.91	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	17.32	1.57	1.84	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	6.87	3.00	2.15	0.00	0.00
occipital pole, adult, pool1	10036-101E9	30.59	11.12	5.28	0.16	0.24
olfactory region, adult	10195-103E6	17.96	9.74	3.63	0.00	0.19
optic nerve, donor1	10277-104E7	12.01	4.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.11	22.78	1.14	0.11	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	7.83	16.49	1.10	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	5.76	0.68	0.85	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	2.31	1.39	0.00	0.00	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	5.88	4.70	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.02	12.15	2.80	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	11.66	6.36	0.42	0.00	0.00
ovary, adult, pool1	10020-101D2	20.53	14.33	0.87	1.48	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.28	15.58	1.10	0.55	0.37
pancreas, adult, donor1	10049-101G4	19.75	22.58	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.90	6.15	0.56	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	7.15	5.79	1.02	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	11.92	3.15	0.50	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	25.44	7.50	4.21	0.18	0.46
parietal cortex, adult, donor10258	10373-105G4	13.95	4.40	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	4.70	4.70	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	28.79	6.27	5.13	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	28.29	9.25	3.44	0.35	0.26
parietal lobe, fetal, donor1	10072-101I9	11.64	2.91	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	14.95	5.61	1.87	0.37	0.00
parotid gland, adult	10199-103F1	33.30	6.78	2.47	0.62	0.00
penis, adult	10200-103F2	18.80	6.45	1.07	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.56	2.42	0.00	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.18	2.62	0.73	0.29	0.44
pineal gland - adult, donor10196	10179-103C8	20.64	8.39	2.58	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	33.16	5.33	4.15	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	47.66	10.66	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	9.11	9.11	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	15.11	6.25	1.56	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	22.13	7.66	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	33.97	3.12	0.54	0.22	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	11.92	7.68	1.19	0.00	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	14.32	4.36	1.25	0.47	0.16
pons, adult, pool1	10033-101E6	18.85	5.85	2.58	0.17	0.26
postcentral gyrus, adult, pool1	10032-101E5	29.03	8.11	4.97	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	16.61	10.20	4.81	0.44	0.00
prostate cancer cell line:PC-3	10439-106E7	15.61	11.43	2.90	0.54	0.73
prostate, adult, pool1	10022-101D4	25.03	9.25	2.45	0.91	0.45
putamen, adult, donor10196	10176-103C5	9.44	5.67	2.83	0.47	0.00
putamen, adult, donor10252	10152-102I8	29.41	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	10.93	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.87	5.32	1.45	0.24	0.00
putamen, newborn, donor10223	10365-105F5	6.00	2.25	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	19.78	15.42	0.29	0.87	1.16
rectum, fetal, donor1	10067-101I4	2.78	2.78	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.06	10.81	1.06	0.64	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	20.71	38.52	3.73	6.21	0.00
retina, adult, pool1	10030-101E3	28.23	9.94	1.09	0.80	0.20
retinoblastoma cell line:Y79	10475-106I7	12.73	21.56	3.12	0.78	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.45	12.42	0.74	0.00	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.65	10.12	0.56	0.56	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	8.34	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	5.34	6.64	0.97	0.49	0.00
salivary acinar cells, donor2	11772-123I8	7.71	4.68	0.83	0.55	0.00
salivary acinar cells, donor3	11773-123I9	11.25	7.28	1.32	1.32	0.66
salivary gland, adult, pool1	10093-102C3	31.46	5.72	4.00	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.30	20.66	0.42	1.01	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.46	21.28	0.59	1.41	0.12
seminal vesicle, adult	10201-103F3	47.62	20.63	2.12	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.25	5.83	0.49	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.36	3.02	3.52	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	5.02	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.71	4.30	1.61	0.13	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	3.09	3.87	0.44	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.29	1.03	0.65	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	4.97	4.97	0.71	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	11.39	8.28	0.36	1.20	0.72
skeletal muscle, fetal, donor1	10066-101I3	7.04	3.02	1.01	2.01	0.00
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	13.89	3.79	0.63	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	6.34	0.67	0.67	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.53	23.01	0.95	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	13.30	2.51	3.66	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	1.15	5.27	0.16	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	47.13	32.81	3.54	0.48	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	16.13	10.24	1.09	0.00	0.44
small intestine, adult, pool1	10024-101D6	111.80	3.82	5.26	0.24	2.03
small intestine, fetal, donor1	10064-101I1	48.89	1.97	0.98	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	10.26	2.05	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	12.92	6.20	0.52	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	13.13	2.14	1.61	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	13.53	5.28	1.15	0.69	0.23
spinal cord, adult, donor10252	10159-103A6	22.08	5.52	0.79	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	17.29	3.46	0.69	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	13.42	2.44	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	16.99	5.05	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.41	2.99	0.30	0.00	0.15
spleen, adult, pool1	10025-101D7	26.32	2.64	2.20	0.44	0.11
spleen, fetal, pool1	10044-101F8	22.96	2.70	0.79	0.24	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	4.55	7.25	1.35	0.10	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	19.94	4.56	0.57	0.38	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	29.70	2.45	1.05	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	4.30	7.04	0.39	0.39	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	5.85	1.46	0.34	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	9.32	5.93	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	7.62	10.58	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	16.02	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	35.89	5.70	2.28	0.00	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	31.57	6.02	1.04	0.42	0.62
substantia nigra, adult, donor10258	10371-105G2	21.21	7.24	2.07	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	10.60	2.83	1.41	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	13.99	13.30	1.60	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	25.60	10.51	4.15	0.59	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.97	2.14	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.91	4.83	1.76	0.00	0.00
tenocyte, donor1	11763-123H8	12.57	2.44	0.70	0.70	0.00
tenocyte, donor2	11765-123I1	14.50	6.49	1.14	0.76	0.00
tenocyte, donor3	11768-123I4	11.49	2.97	0.74	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.58	14.96	3.23	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	14.03	7.09	2.77	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	15.34	6.20	1.08	0.00	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	23.36	4.95	1.90	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.61	4.54	2.65	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.27	3.60	1.42	0.22	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	13.68	9.77	2.28	0.00	0.33
testis, adult, pool1	10026-101D8	15.78	8.27	2.15	1.18	0.11
testis, adult, pool2	10096-102C6	11.28	7.22	0.90	0.00	0.00
thalamus - adult, donor10196	10168-103B6	13.25	8.83	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	27.19	5.00	1.56	0.78	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	38.49	4.62	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.13	4.28	2.47	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	24.16	6.33	1.15	0.00	0.58
throat, adult	10209-103G2	20.47	5.99	1.25	1.00	0.00
throat, fetal, donor1	10061-101H7	9.75	2.44	0.30	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	5.37	9.94	0.79	0.20	0.00
thymus, adult, pool1	10027-101D9	25.85	3.48	1.99	0.10	0.99
thymus, fetal, pool1	10043-101F7	20.57	5.82	1.66	0.21	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	8.51	12.76	1.73	0.80	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	11.18	12.43	0.14	1.12	0.14
thyroid, adult, pool1	10028-101E1	35.09	32.01	1.96	2.15	0.65
thyroid, fetal, donor1	10060-101H6	16.87	6.59	0.26	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	6.16	3.08	0.00	0.00
tongue, adult	10203-103F5	13.02	4.19	1.40	0.23	0.70
tongue, fetal, donor1	10059-101H5	26.40	4.73	1.58	1.18	0.00
tonsil, adult, pool1	10047-101G2	24.44	4.81	2.80	0.10	0.60
trachea, adult, pool1	10029-101E2	20.29	12.11	2.45	1.55	0.16
trachea, fetal, donor1	10058-101H4	13.08	3.85	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	5.67	3.54	1.77	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	5.57	3.55	0.00	0.10	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	21.78	27.73	2.19	1.25	0.00
tridermal teratoma cell line:HGRT	10694-109G1	7.61	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.61	4.15	0.76	0.17	0.17
umbilical cord, fetal, donor1	10057-101H3	4.17	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	23.03	10.07	1.71	1.19	0.68
uterus, fetal, donor1	10055-101H1	6.66	2.05	0.51	0.51	0.51
vagina, adult	10204-103F6	27.14	7.75	0.65	1.29	0.65
vein, adult	10191-103E2	27.84	5.92	1.97	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.61	3.47	0.80	0.00	0.00